Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and cellular DNA and proteins represent the primary macromolecular constituents of life, serving as the storage for genetic information and the machinery for cellular processes (Nature Education, 2014). DNA serves as a therapeutic target for various classes of drugs, including alkylating agents like cyclophosphamide and platinum-based compounds like cisplatin (StatPearls, 2023). These agents form covalent adducts or cross-links that inhibit DNA replication and transcription, ultimately triggering programmed cell death (PubMed, 2021). Proteins are targeted by a vast array of specific inhibitors, but in the context of broad 'cellular proteins,' they are often the subject of non-specific denaturation or cross-linking by chemical disinfectants such as glutaraldehyde (CDC, 2008). Such broad-spectrum targeting is commonly employed in antimicrobial strategies to ensure the complete inactivation of pathogens (NIH, 2022). However, because this 'target' encompasses nearly all functional molecules within a cell, drugs acting upon it often suffer from significant toxicity and a narrow therapeutic window. The lack of specificity between pathogen and host or between cancerous and healthy cells leads to severe side effects like mutagenicity and organ damage (PubChem, 2023). Consequently, modern drug discovery typically focuses on specific enzymes or receptors rather than the broad categories of DNA or proteins as a whole.
Non-specific DNA alkylation, intercalation, and protein cross-linking or denaturation leading to cellular arrest and death.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and cellular DNA and protein.